Wikileaks & the Pharma Scandal
U.S. Government attempts to drive up the price of medicine in developing countries, as described in leaked cables, amounts to state-sponsored violence, writes James Love.
What's the Latest Development?
U.S. Government attempts to drive up the price of medicine in developing countries, as described in leaked cables, amounts to state-sponsored violence, writes James Love. Even when its officials knew, and wrote, that high drug prices would undermine access, "they conspired to undertake all sorts of pressure to get policies favorable to the drug companies."
What's the Big Idea?
A typical but shocking example of this was the U.S. campaign to undermine legislation and reforms to make medicines more affordable in the Philippines, despite its then ambassador to that country acknowledging there was a strong rationale for the Philippines to cut drug prices. "In a number of cases, the US government pressures developing countries to put pharmaceutical company lobbyists on key government committees dealing with drug regulation, IPR policy or drug pricing."
Upvote/downvote each of the videos below!
Having these financial life skills can help you navigate challenging economic environments.
- Americans are swimming in increasingly higher amounts of debt, even the upper middle class.
- Here's some essential financial life skills needed to ensure your economic wellbeing.
An innovation may lead to lifelike evolving machines.
- Scientists at Cornell University devise a material with 3 key traits of life.
- The goal for the researchers is not to create life but lifelike machines.
- The researchers were able to program metabolism into the material's DNA.
Experts argue the jaws of an ancient European ape reveal a key human ancestor.
- The jaw bones of an 8-million-year-old ape were discovered at Nikiti, Greece, in the '90s.
- These fossils may change how we view the evolution of our species.
Rethinking humanity's origin story
Migrating out of Africa
Did we head east or south of Eden?
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.